E4MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
E4MEDICAL
Largest movements
- Receivables within one year +€414,737
up €414,737 (+121%), from €342,229 to €756,966
of which Trade receivables: +€469,314
- Cash -€132,418
down €132,418 (-17.0%), from €779,985 to €647,566
mainly Receivables within one year (-€414,737) and Contributions, distributions and other (-€100,000)
- Profit (loss) carried forward +€194,277
up €194,277 (+19.7%), from €986,799 to €1.2m
- Trade debts +€119,972
up €119,972 (+129%), from €93,045 to €213,017
- Other debts -€39,510
down €39,510 (-100.0%), from €39,510 to €0
- Gross operating margin +€141,647
up €141,647 (+56.2%), from €251,873 to €393,520
- Taxes +€44,847
up €44,847 (+83.7%), from €53,596 to €98,443
- Financial charges -€3,980
down €3,980 (-88.5%), from €4,496 to €515
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,133,350 | €1,416,532 | +€283,182 | +25.0% |
| Current assets | 29/58 | €1,133,350 | €1,416,532 | +€283,182 | +25.0% |
| Stocks and contracts in progress | 3 | €11,136 | €12,000 | +€864 | +7.8% |
| Stocks | 30/36 | €11,136 | €12,000 | +€864 | +7.8% |
| Amounts receivable within one year | 40/41 | €342,229 | €756,966 | +€414,737 | +121% |
| Trade receivables | 40 | €287,143 | €756,458 | +€469,314 | +163% |
| Other amounts receivable | 41 | €55,086 | €508 | -€54,578 | -99.1% |
| Cash at bank and in hand | 54/58 | €779,985 | €647,566 | -€132,418 | -17.0% |
| Total equity and liabilities | 10/49 | €1,133,350 | €1,416,532 | +€283,182 | +25.0% |
| Equity | 10/15 | €1,000,794 | €1,195,071 | +€194,277 | +19.4% |
| Contributions | 10/11 | €12,500 | €12,500 | = | 0.0% |
| Reserves | 13 | €1,495 | €1,495 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,250 | €1,250 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,250 | €1,250 | = | 0.0% |
| Distributable reserves | 133 | €245 | €245 | = | 0.0% |
| Profit (loss) carried forward | 14 | €986,799 | €1,181,076 | +€194,277 | +19.7% |
| Amounts payable | 17/49 | €132,556 | €221,461 | +€88,905 | +67.1% |
| Amounts payable within one year | 42/48 | €132,556 | €221,461 | +€88,905 | +67.1% |
| Trade debts | 44 | €93,045 | €213,017 | +€119,972 | +129% |
| Suppliers | 440/4 | €93,045 | €213,017 | +€119,972 | +129% |
| Taxes, remuneration and social security | 45 | - | €8,443 | +€8,443 | |
| Taxes | 450/3 | - | €8,443 | +€8,443 | |
| Other amounts payable | 47/48 | €39,510 | €0 | -€39,510 | -100.0% |
| Other operating charges | 640/8 | €665 | €285 | -€381 | -57.2% |
| Gross operating margin | 9900 | €251,873 | €393,520 | +€141,647 | +56.2% |
| Operating profit (loss) | 9901 | €251,208 | €393,236 | +€142,027 | +56.5% |
| Financial income | 75/76B | €10 | - | -€10 | |
| Recurring financial income | 75 | €10 | - | -€10 | |
| Financial charges | 65/66B | €4,496 | €515 | -€3,980 | -88.5% |
| Recurring financial charges | 65 | €4,496 | €515 | -€3,980 | -88.5% |
| Profit (loss) for the period before taxes | 9903 | €246,723 | €392,720 | +€145,998 | +59.2% |
| Income taxes | 67/77 | €53,596 | €98,443 | +€44,847 | +83.7% |
| Profit (loss) for the period | 9904 | €193,127 | €294,277 | +€101,150 | +52.4% |
| Profit (loss) for the period to be appropriated | 9905 | €193,127 | €294,277 | +€101,150 | +52.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.